Study to assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043

Study identifier:D0510C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:2007-003474-26

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Single-Centre, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous AZD3043 after Single Ascending Doses in Healthy Male Volunteers

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD3043

Sex

Male

Actual Enrollment

53

Study type

Interventional

Age

18 Years - 45 Years

Date

Study Start Date: 01 May 2009
Primary Completion Date: -
Study Completion Date: 01 Aug 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria